AI Summary

More than 2,300 individuals who have used regulated psilocybin services in Oregon and Colorado have reported their real‑world outcomes, according to a new analysis. The report notes that while clinical trials of psilocybin often show promising results, those studies involve extensive prescreening that excludes many potential users. Consequently, the findings suggest that experiences outside trial settings may differ from trial data, highlighting a gap between controlled research and broader community use.

AI summaries can be wrong sometimes—always verify important details using the source article.